Sep 24, 2014 · the lawsuits were filed under the false claims act’s whistleblower provisions, which permit private parties to sue for false claims on behalf of the government and to share in. Extract from the clinical evaluation report for lisdexamfetamine dimesilate proprietary product name: Dec 15, 2014 · the lawsuits were filed under the false claims act’s whistleblower provisions, which permit private parties to sue for false claims on behalf of the government and to share in. Nov 1, 2024 · soon after vyvanse’s patent expired in 2023, applications for generic formulations of lisdexamfetamine dimesylate started flowing into the fda. There are now 18 approved.
Physicians should assess the risk of abuse.
Morgan Vera: Life After The Public Exposure
Her Life In One Photo: Belinda Nohemy's Incredible Journey
Celina Smith's Secret Files: The Biggest Scandal Yet!